Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerri Barton

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Maine Medical Center|August 9, 2024
Patient and Provider Experience with Artificial Intelligence Screening Technology for Diabetic Retinopathy in a Rural Primary Care SettingBrian Nolan, Emma R Daybranch, Kerri Barton, et al.
Public Health Reports (Washington, D.C. : 1974)|September 2, 2014
Follow-up testing for hepatitis C virus infection: an analysis of Massachusetts surveillance data, 2007-2010Kerri Barton, Dan Church, Shauna Onofrey, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 6, 2020
Anomalous Antimicrobial Susceptibility Trend Identification<sup>.</sup>M L Tlachac, Elke Rundensteiner, Kerri Barton, et al.
American Journal of Infection Control|October 11, 2018
Using public health surveillance data to measure Clostridium difficile infection population burden in MassachusettsT Scott Troppy, Tej Mishra, Kerri Barton, et al.
Infection Control and Hospital Epidemiology|August 28, 2020
Utilization of cumulative antibiograms for public health surveillance: Trends in <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> susceptibility, Massachusetts, 2008-2018Quynh T Vo, R Monina Klevens, Barbara Bolstorff, et al.
BMC Infectious Diseases|April 22, 2017
Identifying and characterizing hepatitis C virus hotspots in Massachusetts: a spatial epidemiological approachThomas J Stopka, Michael A Goulart, David J Meyers, et al.
Journal of Clinical Gastroenterology|April 20, 2016
Postpartum Laboratory Follow-up in Women With Hepatitis B in Massachusetts From 2007 to 2012Matthew S Chang, Kerri Barton, Molly Crockett, et al.
Journal of Substance Use and Addiction Treatment|May 12, 2024
Perspectives on benefits and risks of creation of an "injection drug use" billing codeGayathri Sundaram, Taisuke Sato, David Goodman-Meza, et al.
Annals of Internal Medicine|June 30, 2015
Underascertainment of acute hepatitis C virus infections in the U.S. surveillance system: a case series and chart reviewShauna Onofrey, Jasneet Aneja, Gillian A Haney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Transmission of Mobile Colistin Resistance (mcr-1) by DuodenoscopeErica S Shenoy, Virginia M Pierce, Maroya Spalding Walters, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Maine Medical Center|August 9, 2024
Patient and Provider Experience with Artificial Intelligence Screening Technology for Diabetic Retinopathy in a Rural Primary Care SettingBrian Nolan, Emma R Daybranch, Kerri Barton, et al.
Public Health Reports (Washington, D.C. : 1974)|September 2, 2014
Follow-up testing for hepatitis C virus infection: an analysis of Massachusetts surveillance data, 2007-2010Kerri Barton, Dan Church, Shauna Onofrey, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 6, 2020
Anomalous Antimicrobial Susceptibility Trend Identification<sup>.</sup>M L Tlachac, Elke Rundensteiner, Kerri Barton, et al.
American Journal of Infection Control|October 11, 2018
Using public health surveillance data to measure Clostridium difficile infection population burden in MassachusettsT Scott Troppy, Tej Mishra, Kerri Barton, et al.
Infection Control and Hospital Epidemiology|August 28, 2020
Utilization of cumulative antibiograms for public health surveillance: Trends in <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> susceptibility, Massachusetts, 2008-2018Quynh T Vo, R Monina Klevens, Barbara Bolstorff, et al.
BMC Infectious Diseases|April 22, 2017
Identifying and characterizing hepatitis C virus hotspots in Massachusetts: a spatial epidemiological approachThomas J Stopka, Michael A Goulart, David J Meyers, et al.
Journal of Clinical Gastroenterology|April 20, 2016
Postpartum Laboratory Follow-up in Women With Hepatitis B in Massachusetts From 2007 to 2012Matthew S Chang, Kerri Barton, Molly Crockett, et al.
Journal of Substance Use and Addiction Treatment|May 12, 2024
Perspectives on benefits and risks of creation of an "injection drug use" billing codeGayathri Sundaram, Taisuke Sato, David Goodman-Meza, et al.
Annals of Internal Medicine|June 30, 2015
Underascertainment of acute hepatitis C virus infections in the U.S. surveillance system: a case series and chart reviewShauna Onofrey, Jasneet Aneja, Gillian A Haney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Transmission of Mobile Colistin Resistance (mcr-1) by DuodenoscopeErica S Shenoy, Virginia M Pierce, Maroya Spalding Walters, et al.
Pageof 2